Advancing mRNA Therapeutics: A New Frontier in the Treatment of Obesity & Metabolic Disease
Time: 11:15 am
day: Day 1 Track 1 AM
Details:
- Presenting new preclinical data from WestGene’s obesity program, demonstrating significant weight loss and metabolic improvements
- Highlighting how WestGene’s proprietary mRNA-encoded antibody platform drives these results and opens new possibilities for therapeutic innovation
- Exploring the platform’s broader potential, using the obesity project as a key example of its applications in metabolic diseases, oncology, and other critical areas
